Skip to main content

Peer Review reports

From: The potential of PARP as a therapeutic target across pediatric solid malignancies

Original Submission
27 Sep 2022 Submitted Original manuscript
20 Oct 2022 Reviewed Reviewer Report
27 Oct 2022 Reviewed Reviewer Report - Avanti Gupte
4 Nov 2022 Author responded Author comments - Jan J. Molenaar
Resubmission - Version 2
4 Nov 2022 Submitted Manuscript version 2
Publishing
15 Nov 2022 Editorially accepted
5 Apr 2023 Article published 10.1186/s12885-022-10319-7

You can find further information about peer review here.

Back to article page